IRON
Disc Medicine, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website discmedicine.com
- Employees(FY) 60
- ISIN US2546041011
Performance
+4.58%
1W
+7.52%
1M
-51.18%
3M
-33.46%
6M
-44.29%
YTD
-5.49%
1Y
Profile
Disc Medicine, Inc., together with its subsidiaries, operates as a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.
Investment Analysis Report: IRON
Overview
IRON is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $1,591,337,079. In this report, we will conduct a comprehensive analysis of IRON's financial statements over the past three years, focusing on the Balance Sh...
Technical Analysis of IRON 2024-05-10
Overview:
In analyzing the technical indicators for IRON stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining key metrics such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to...
Recent News & Updates
- 2024-05-14 10:30
- 2024-05-13 22:30
- 2024-05-13 08:00
- 2024-05-12 20:00
- 2024-05-11 05:31
- 2024-05-09 08:00
- 2024-05-09 01:54
IRON Stock Earnings: Disc Medicine Misses EPS for Q1 2024(Investorplace)
- 2024-05-08 20:00
- 2024-04-04 13:21
- 2024-04-02 14:24
- 2024-04-02 02:24
- 2024-04-01 16:19
Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study(Investor's Business Daily)
- 2024-04-01 09:06
Disc Medicine Plummets 59% After Placebo Effect Confounds Sunlight Sensitivity Study(Investor's Business Daily)
- 2024-04-01 08:00
- 2024-03-31 20:00
- 2024-03-23 05:31
- 2024-03-21 08:00
- 2024-03-20 20:00
- 2024-03-06 16:30
- 2024-03-06 03:30
- 2024-02-26 08:30
- 2024-02-25 19:30
- 2024-02-20 08:30
- 2024-02-19 19:30
- 2024-02-09 09:00
- 2024-02-08 20:00
- 2024-02-06 19:00
- 2024-02-06 19:00
- 2024-01-26 06:30
Daily – Vickers Top Buyers & Sellers for 01/26/2024(Argus Research)
- 2024-01-16 06:26
Daily – Vickers Top Buyers & Sellers for 01/16/2024(Argus Research)
Page 1 of 3
previousnext